Last viewed:
AXLA
Prices are updated after-hours
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
(0.0% 1d)
(0.0% 1m)
(992.6% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(1982.28%
volume)
Earnings Calendar: 2023-10-31
Market Cap: $ 13,500,512
http://www.axcellahealth.com
Sec
Filling
|
Patents
| 64 employees
Axcella Health, Inc. is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. Its product pipeline includes AXA1665, AXA1125, AXA1957, AXA2678, and AXA4010. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.
metabolic
add to watch list
Paper trade
email alert is off
Press-releases
Advanced Therapeutics Pharmaceutical Outsourcing Market to Surge at a CAGR of 4.4% by 2034 Amid Growing Demand for Personalized Medicine
Published: 2024-01-16
(Crawled : 15:00)
- prnewswire.com
LH
M
|
$207.97
2.41%
0.0%
930K
|
Health Services
| -9.13%
| O: -0.69%
H: 0.46%
C: -0.08%
CRL
|
News
|
$240.13
3.26%
0.0%
610K
|
Commercial Services
| 9.96%
| O: -1.58%
H: 0.17%
C: -0.83%
CTLT
|
$56.03
-0.04%
0.0%
1.5M
|
Health Technology
| 13.62%
| O: -0.63%
H: 0.97%
C: 0.82%
ICLR
|
News
|
$306.16
2.76%
2.68%
810K
|
Health Technology
| 16.84%
| O: -1.27%
H: 1.62%
C: -0.33%
growing
therapeutics
advanced
market
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
Published: 2023-09-05
(Crawled : 11:00)
- prnewswire.com
SRPT
|
$117.065
0.09%
0.09%
440K
|
Health Technology
| -4.53%
| O: -0.38%
H: 0.42%
C: -1.2%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
| -13.78%
| O: -0.93%
H: 0.0%
C: 0.0%
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 1437.43%
| O: 26.82%
H: 4.34%
C: -6.03%
ARQT
|
$8.735
-2.29%
-2.35%
1.6M
|
Health Technology
| -0.22%
| O: 0.22%
H: 2.39%
C: -7.8%
Axcella Granted Patent for Long COVID Fatigue Treatment
Published: 2023-08-29
(Crawled : 14:00)
- biospace.com/
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 3960.28%
| O: 221.81%
H: 39.94%
C: 23.97%
patent
covid
granted
treatment
Axcella Reports Second Quarter Financial Results and Provides Business Update - August 3, 2023
Published: 2023-08-03
(Crawled : 12:20)
- biospace.com/
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 2363.69%
| O: 4.41%
H: 2.52%
C: -4.07%
business
update
financial
results
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors
Published: 2023-06-13
(Crawled : 11:00)
- investor.alkermes.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
| -92.45%
| O: -47.17%
H: 110.71%
C: 96.43%
IRM
A
|
$76.6
0.99%
0.0%
770K
|
Finance
| 34.56%
| O: -0.18%
H: 0.94%
C: 0.2%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
| 64.23%
| O: -0.37%
H: 0.84%
C: 0.46%
AMRX
|
$5.4
0.56%
0.56%
1.4M
|
Health Technology
| 113.1%
| O: 0.4%
H: 8.7%
C: 1.98%
ZLAB
|
$15.13
0.93%
0.93%
470K
|
Health Technology
| -45.75%
| O: 0.94%
H: 0.0%
C: -0.93%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
| 16.72%
| O: 0.08%
H: 1.04%
C: 0.36%
UTHR
|
$234.445
0.16%
0.16%
420K
|
Health Technology
| 2.7%
| O: -0.65%
H: 2.13%
C: 1.37%
RARE
F
|
$45.06
3.14%
3.04%
840K
|
Health Technology
| -15.0%
| O: 0.72%
H: 2.22%
C: 0.5%
SRPT
|
$117.065
0.09%
0.09%
440K
|
Health Technology
| -10.08%
| O: 0.55%
H: 2.23%
C: -0.71%
SAGE
|
$12.94
0.39%
0.39%
810K
|
Health Technology
| -77.64%
| O: 0.07%
H: 2.89%
C: 1.85%
PTCT
|
News
S
|
$25.38
-2.27%
-2.32%
750K
|
Health Technology
| -40.09%
| O: -0.3%
H: 2.48%
C: 1.97%
PRTA
4
|
$20.565
-3.41%
-3.53%
440K
|
Health Technology
| -70.84%
| O: 0.29%
H: 5.34%
C: 4.38%
NBIX
|
News
M
|
$140.11
4.83%
4.6%
1.6M
|
Health Technology
| 42.97%
| O: 0.05%
H: 2.35%
C: 2.29%
MDXG
|
$6.505
2.28%
2.23%
750K
|
Health Technology
| 7.8%
| O: 0.85%
H: 1.34%
C: -0.17%
LPTX
|
$3.24
0.94%
0.93%
89K
|
Health Technology
| -51.71%
| O: 0.0%
H: 9.63%
C: 9.63%
JAZZ
|
$109.685
0.79%
0.78%
380K
|
Health Technology
| -13.36%
| O: -0.02%
H: 1.93%
C: 1.16%
IRWD
|
$8.305
3.04%
2.95%
2.1M
|
Health Technology
| -29.42%
| O: 0.0%
H: 0.35%
C: -3.42%
IONS
|
$41.85
1.9%
1.86%
630K
|
Health Technology
| -1.35%
| O: 0.17%
H: 1.25%
C: 0.46%
INFI
|
$0.016
12.5%
1.1M
|
Health Technology
| -91.05%
| O: 0.0%
H: 0.0%
C: -5.76%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
| -16.39%
| O: -0.48%
H: 1.44%
C: 0.24%
IDXX
|
$494.0
3.01%
2.92%
540K
|
Health Technology
| 4.15%
| O: 0.31%
H: 1.9%
C: 1.42%
EXEL
|
$23.295
1.86%
1.82%
1.9M
|
Health Technology
| 19.8%
| O: 0.05%
H: 0.89%
C: 0.52%
CYCN
|
$3.05
-12.54%
130
|
Health Technology
| -29.89%
| O: 6.44%
H: 0.41%
C: -1.94%
BPMC
|
$92.32
1.89%
1.85%
780K
|
Health Technology
| 57.23%
| O: 0.62%
H: 2.47%
C: 0.53%
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 1377.42%
| O: -1.06%
H: 6.94%
C: -2.15%
ALNY
|
$146.06
0.19%
0.18%
540K
|
Health Technology
| -24.5%
| O: 0.07%
H: 2.64%
C: 2.23%
ALKS
|
$24.26
0.79%
0.78%
1.2M
|
Health Technology
| -22.9%
| O: 0.19%
H: 1.58%
C: 0.64%
ACAD
|
News
|
$16.735
-1.5%
-1.52%
1.5M
|
Health Technology
| -30.96%
| O: 0.12%
H: 1.83%
C: 1.58%
IBIO
|
$1.9
6.74%
0.0%
150K
|
Health Technology
| 144.34%
| O: 16.68%
H: 3.53%
C: -11.59%
Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023
Published: 2023-04-17
(Crawled : 14:00)
- biospace.com/
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 1111.96%
| O: -6.4%
H: 10.83%
C: -0.54%
axa1125
covid
Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Published: 2023-03-30
(Crawled : 14:00)
- biospace.com/
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 957.74%
| O: 6.24%
H: 10.83%
C: 8.74%
business
year
update
financial
results
Axcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
Published: 2023-02-15
(Crawled : 23:00)
- biospace.com/
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 617.76%
| O: -1.27%
H: 1.27%
C: -4.32%
axa1125
fda
clearance
covid
Axcella Announces Program Reprioritization and Corporate Restructuring
Published: 2022-12-15
(Crawled : 08:00)
- biospace.com/
SLRC
|
$15.42
1.38%
1.36%
350K
|
Finance
| 3.26%
| O: -0.2%
H: 0.2%
C: -1.09%
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 413.51%
| O: -11.71%
H: 0.0%
C: -44.25%
program
Axcella Reports Third Quarter Financial Results and Provides Business Update
Published: 2022-11-01
(Crawled : 12:00)
- biospace.com/
AXLA
|
$4.58
-56.33%
42K
|
Health Technology
| 281.67%
| O: 1.67%
H: 0.0%
C: -9.43%
financial
update
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount